ID   Y79-6
AC   CVCL_VA40
SY   Y79c6
DR   Wikidata; Q54995194
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=2946282;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Misspelling: V79c6; PubMed=2946282.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
RX   PubMed=1682862; DOI=10.1016/S0161-6420(91)32134-1;
RA   Chan H.S.L., Thorner P.S., Haddad G., Gallie B.L.;
RT   "Multidrug-resistant phenotype in retinoblastoma correlates with
RT   P-glycoprotein expression.";
RL   Ophthalmology 98:1425-1431(1991).
//
RX   PubMed=2751270;
RA   Chan H.S.L., Canton M.D., Gallie B.L.;
RT   "Chemosensitivity and multidrug resistance to antineoplastic drugs in
RT   retinoblastoma cell lines.";
RL   Anticancer Res. 9:469-474(1989).
//
RX   PubMed=2946282; DOI=10.1001/archopht.1986.01050230131048;
RA   Rootman J., Gallie B.L., Kumi C., Bussanich N., Rogers B.J., Palcic B.;
RT   "Ocular penetration, toxicity, and radiosensitization effects of two
RT   hypoxic cell radiosensitizers on retinoblastoma.";
RL   Arch. Ophthalmol. 104:1693-1697(1986).
//